Holding(s) in Company
On October 2, 2025, Renalytix PLC received notification that UBS Group AG's investment bank and global wealth management holdings fell below the 5% reporting threshold on September 30, 2025. As a result, UBS's voting rights attached to shares decreased from 7.821175% to 0.000000%, representing zero voting rights. The percentage of voting rights through financial instruments also stands at 0.000000%. Consequently, the total voting rights held in the issuer are now zero. The previous notification indicated a 7.821175% holding, which has now been reduced to a level exempt from reporting requirements.
Select text to share a quote on X · sign in to keep highlights & notes in your RENX notes
- Reason for the notification (please mark the appropriate box or boxes with an "X")
| An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Details of person subject to the notification obligation iv
| Name | UBS Group AG - Investment Bank & Global Wealth Management |
| City and country of registered office (if applicable) | Z ürich Switzerland |
Full name of shareholder(s) (if different from 3.) v
Name
City and country of registered office (if applicable)
| 5. Date on which the threshold was crossed or reached vi : | 30 September 2025 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 02 October 2025 |
- Total positions of person(s) subject to the notification obligation
| % of voting rights attached to shares (total of 8. A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer (8.A + 8.B) vii | |
|---|---|---|---|---|
| Resulting situation on the date on which threshold was crossed or reached | 0.000000% | 0.000000% | 0.000000% | 0 |
| Position of previous notification (if applicable) | 7.821175% | 0.000000% | 7.821175% | |
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| GB00BYWL4Y04 | 0 | 0.000000% | ||
| SUBTOTAL 8. A | 0 | 0.000000% | ||
| B 1: Financial Instruments according to DTR5.3.1R (1) (a) | ||||
| Type of financial instrument | Expiration date x | Exercise/ Conversion Period xi | Number of voting rights that may be acquired if the instrument is exercised/converted. | % of voting rights |
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
| Type of financial instrument | Expiration date x | Exercise/ Conversion Period xi | Physical or cash Settlement xii | Number of voting rights | % of voting rights |
| SUBTOTAL 8.B.2 | |||||
| Name xv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold | ||
UBS Group AG
UBS AG
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
UBS trading book holdings in Renalytix PLC fell below 5% and are therefore exempt from reporting.
| Place of completion | Zurich, Switzerland |
|---|---|
| Date of completion | 02.10.2025 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.